Solara Active PP

Why is Solara Active Pharma Sciences Ltd Partly Paidup falling/rising?

As of 19-Jun, the stock price of Solara Active Pharma Sciences Ltd is stable at 308.70, despite a year-to-date decline of 18.78%. While it opened with a gain today, the overall trend remains negative with reduced investor participation and erratic trading patterns.

As of 19-Jun, the stock price of Solara Active Pharma Sciences Ltd Partly Paidup is currently stable at 308.70, showing no change from the previous trading session. Despite this stability in price, the stock has experienced a significant decline over the year, with a year-to-date drop of 18.78% compared to a 9.88% decline in the benchmark Sensex. <BR><BR>Today, the stock opened with a notable gain of 12.87%, reaching an intraday high of Rs 308.70, which indicates a positive movement at the start of the trading day. Additionally, it outperformed its sector by 13.15%. However, the stock has not traded on one day out of the last 20 days, indicating erratic trading patterns. <BR><BR>Moreover, while the stock is currently trading above its 5-day and 20-day moving averages, it remains below its 50-day, 100-day, and 200-day moving averages, suggesting that it may not be on a strong upward trend in the longer term. Furthermore, there has been a decline in investor participation, with delivery volume falling by 14.1% against the 5-day average, which could indicate waning interest among investors.<BR><BR>In summary, while there was a positive opening and some short-term gains today, the overall trend for Solara Active Pharma Sciences Ltd remains negative, with significant declines over the year and reduced investor participation.

Which are the latest news on Solara Active PP?

What does Solara Active PP do?

Solara Active Pharma Sciences Ltd Partly Paidup operates in the Pharmaceuticals & Biotechnology sector as a Micro Cap company with a market cap of INR 370 Cr. It has reported no sales or profits recently, and key financial metrics indicate a lack of earnings and dividends.

Overview:<BR>Solara Active Pharma Sciences Ltd Partly Paidup operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The incorporation year and any status changes are not available, and there are no reported sales or profits for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 370 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>Industry P/E: N/A<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.00<BR>Return on Equity: 0.00%<BR>Price to Book: 0.00<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Solara Active PP?

As of 10th June, Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 370.00 Cr, classified as a Micro Cap, with no valid data available for recent net sales, net profit, shareholder's funds, or total assets.

As of 10th June, <BR><BR>Market Cap: Solara Active Pharma Sciences Ltd Partly Paidup has a market capitalization of 370.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid data available for Net Sales and Net Profit for the latest 4 quarters.<BR><BR>Balance Sheet Snapshot: There is no valid data available for the latest annual period regarding Shareholder's Funds and Total Assets.

Who are the peers of the Solara Active PP?

Peers of Solara Active PP include Parmax Pharma, Starsource Multi, Zenith Health, Ortin Global, Colinz Labs, Beryl Drugs, Unjha Formul., Ganga Pharma, and Saroja Pharma In. Parmax Pharma leads in 1-year returns at 48.68%, while Zenith Health has the lowest at -28.79%, and Solara Active PP's return is -13.53%.

Peers: The peers of Solara Active PP are Parmax Pharma, Starsource Multi, Zenith Health, Ortin Global, Colinz Labs, Beryl Drugs, Unjha Formul., Ganga Pharma., and Saroja Pharma In.<BR><BR>Quality Snapshot: Below Average management risk is observed at Parmax Pharma, Zenith Health, Ortin Global, Colinz Labs, Beryl Drugs, and Ganga Pharma., while Average management risk is found at Unjha Formul. and Saroja Pharma In. Starsource Multi does not qualify for management risk assessment. Below Average growth is noted for Parmax Pharma, Zenith Health, Ortin Global, Colinz Labs, Beryl Drugs, Ganga Pharma., and Saroja Pharma In, while Average growth is seen at Unjha Formul. Starsource Multi does not qualify for growth assessment. Good capital structure is present at Zenith Health, Colinz Labs, and Unjha Formul., while the rest have Below Average capital structure.<BR><BR>Return Snapshot: Parmax Pharma has the highest 1-year return at 48.68%, while Zenith Health has the lowest at -28.79%. Solara Active PP's own 1-year return is -13.53%, which is better than Zenith Health but worse than Parmax Pharma. Additionally, Ganga Pharma. and Saroja Pharma In have negative six-month returns.

What is the technical trend for Solara Active PP?

As of June 4, 2025, Solara Active PP shows a neutral trend with a slight bullish inclination due to a mildly bullish weekly MACD and RSI, despite daily moving averages being mildly bearish and no clear trend from Dow Theory and OBV.

As of 4 June 2025, the technical trend for Solara Active PP has changed from mildly bearish to sideways. The weekly MACD is mildly bullish, and the RSI is bullish, indicating some positive momentum in the short term. However, daily moving averages are mildly bearish, suggesting caution. The Bollinger Bands on the weekly chart are also bullish, supporting the upward potential. Dow Theory and OBV show no clear trend in both weekly and monthly time frames, indicating a lack of strong directional movement. Overall, the current stance is neutral with a slight bullish inclination, driven primarily by the weekly MACD and RSI.

How has been the historical performance of the Solara Active PP?

No Data Available for this Stock

When is the next results date for Solara Active PP?

No Upcoming Board Meetings

Has Solara Active PP declared dividend?

No Dividend History Available